CG
Insider
Cam Gallagher
DirectorCam Gallagher (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Opus Genetics, Inc. (IRD). Across 1 priced purchase filing, the average 21-session return was +35.0% from execution and +18.5% from disclosure (delay-adjusted; derived). The largest single filing was $324K of IRD (164,000 sh across 2 lots, as filed), executed Dec 29 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+35.0%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+18.5%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$324K
shares × price, as filed
Last traded
Dec 29 2025
Filed Dec 31 2025
Median ADV $4.8M across their filed names
Open performance→Volume by month
Buys $324K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
IRD
Opus Genetics, Inc.
IRD · 1 buy · 0 sells
1 filing
Recent filings
IRDPURCHASE
Opus Genetics, Inc.
View filing →
$324K164,000 sh across 2 lots
Exec Dec 29 2025
Filed Dec 31 2025 · 4:33 PM ET